October 6, 2022 | Healthcare Marketing, Marketing, healthcare communications, marketing campaigns, rare diseases
Sanofi Genzyme wanted to reach haematologists; the specialist physicians most likely to encounter patients with Gaucher Disease prior to diagnosis. The problem? Gaucher Disease is considered very rare and its symptoms often misdiagnosed.
The brief
Sanofi Genzyme wanted to reach haematologists; the specialist physicians most likely to encounter patients with Gaucher Disease prior to diagnosis. The problem? Gaucher Disease is considered very rare and its symptoms often misdiagnosed.
The insight
Haematologists have the patient’s best interests at heart, but are fixated on diagnosing the condition, so often look for the knowns rather than considering rare diseases.
Our strategy
To remove the label of ‘rare’ so that haematologists didn’t automatically switch off and think about Gaucher Disease as a condition they would never encounter. Then using a new diagnostic algorithm (Cappellini) we encouraged haematologists to test for Gaucher Disease as soon as malignancies had been ruled out. To gain stand out we used the well-known cross-examining game of ‘Guess Who?’ as our creative wrapper. Entitled ‘Guess What?’ our campaign played on how to analyse the characteristics of the symptoms left, reducing the chance of misdiagnosis and unnecessary treatments for sufferers.
This content was provided by Create Health
Company Details
Latest Content from Create Health
Eight new recruits, including Business Development Director, Marketing Manager and Medical Writer join Create Health.
In Vitro Diagnostic Regulation (IVDR 2022) was on the horizon: a new regulatory basis for laboratories to adhere to regarding their diagnostic equipment and tests. BD wanted to let their customers…
1 in 10 UK children suffer with a mental health issue and alarmingly as many as 70% of these don’t receive the proper support they need. That’s why The Anna…
Sanofi Genzyme wanted to reach haematologists; the specialist physicians most likely to encounter patients with Gaucher Disease prior to diagnosis. The problem? Gaucher Disease is considered very rare and its…
There’s a huge amount of fear around health conditions and disease – in fact according to Harvard Medical School, health anxiety affects 12% of adults. We wanted to put a…
ConvaTec launched AQUACEL Ag+ in 2014, a new class of dressing proven to disrupt and destroy biofilm. They came to us to help them position AQUACEL Ag+ as the solution…
Though BD is very well known within the immunology and flowcytometry space, there is low awareness that BD is the only brand with a true multiomics offering. BD wanted to…
Thermo Fisher Scientific came to us when they needed to communicate their New Generation food production technologies.
Vagisil were launching their first product available on prescription. It was a tough task to put Vagisil ProHydrate front of mind and turn GPs into advocates. That’s why they came…
